Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

about

Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

Item

http://www.wikidata.org/entity/Q55194285

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Targeting Clostridium difficil ...... ostridium difficile Infection.

@en

Targeting Clostridium difficil ...... ostridium difficile Infection.

@nl

type

Item

label

Targeting Clostridium difficil ...... ostridium difficile Infection.

@en

Targeting Clostridium difficil ...... ostridium difficile Infection.

@nl

prefLabel

Targeting Clostridium difficil ...... ostridium difficile Infection.

@en

Targeting Clostridium difficil ...... ostridium difficile Infection.

@nl

P1476

Targeting Clostridium difficil ...... lostridium difficile Infection

@en

P2093

Anne Collignon

http://www.w3.org/2001/XMLSchema#string

Claire Janoir

http://www.w3.org/2001/XMLSchema#string

Séverine Péchiné

http://www.w3.org/2001/XMLSchema#string

P2860

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

Clostridium difficile spore biology: sporulation, germination, and spore structural proteins

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Immune responses to Clostridium difficile infection

Characterization of a cell surface protein of Clostridium difficile with adhesive properties

Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.

Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

P304

1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMICB.2018.01009

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean F Bruxelle

P577

2018-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29875742

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Clostridium difficile

P932

5974105

http://www.w3.org/2001/XMLSchema#string